drugset / Trial / NCT02815592
Trial of BMS-986012 in Combination With Platinum and Etoposide
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this this study is to administer BMS-986012 in Combination with Platinum and Etoposide as First-line Therapy in Extensive Small Cell Lung Cancer.
Timeline
- Start
- 2016-11-28
- Primary completion
- 2019-12-15
- Completion
- 2024-08-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | atigotatug | Monoclonal antibody | — | — |
| Background | Etoposide | Small molecule | — | — |